[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@Generic_Tina Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1511682976639119365.png) @Generic_Tina Tina Banerjee

Tina Banerjee posts on X about japan, $4503t, canada, $4506t the most. They currently have XX followers and XXX posts still getting attention that total X engagements in the last XX hours.

### Engagements: X [#](/creator/twitter::1511682976639119365/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1511682976639119365/c:line/m:interactions.svg)

- X Week XXX +70%
- X Month XXX -XXXX%
- X Months XXXXX +100%
- X Year XXXXXX +304%

### Mentions: X [#](/creator/twitter::1511682976639119365/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1511682976639119365/c:line/m:posts_active.svg)

- X Week XX +50%
- X Month XX -XX%
- X Months XXX +55%
- X Year XXX +251%

### Followers: XX [#](/creator/twitter::1511682976639119365/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1511682976639119365/c:line/m:followers.svg)

- X Week XX no change
- X Month XX -XXXX%
- X Months XX +26%

### CreatorRank: undefined [#](/creator/twitter::1511682976639119365/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1511682976639119365/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1511682976639119365/influence)
---

**Social category influence**
[countries](/list/countries)  XXXX% [finance](/list/finance)  XXXX% [travel destinations](/list/travel-destinations)  XXXX%

**Social topic influence**
[japan](/topic/japan) 1.16%, [$4503t](/topic/$4503t) 0.58%, [canada](/topic/canada) 0.58%, [$4506t](/topic/$4506t) 0.58%, [$8053t](/topic/$8053t) 0.58%, [novo](/topic/novo) 0.58%, [knight](/topic/knight) 0.58%, [hong kong](/topic/hong-kong) 0.58%, [ipo](/topic/ipo) 0.58%, [china](/topic/china) XXXX%

**Top accounts mentioned or mentioned by**
[@smartkarma](/creator/undefined)
### Top Social Posts [#](/creator/twitter::1511682976639119365/posts)
---
Top posts by engagements in the last XX hours

"Astellas Pharma's Izervay receives conditional approval in Japan for age-related macular degeneration. Izervay witnessed record high sales in Q1FY26 and a revenue growth of XX% is expected for FY26"  
[X Link](https://x.com/Generic_Tina/status/1973909683137282450) [@Generic_Tina](/creator/x/Generic_Tina) 2025-10-03T00:35Z XX followers, XX engagements


"Sumitomo Pharma partners with Knight Therapeutics for exclusive licensing agreements in Canada and with Novo Nordisk in Japan for co-promotion of Ozempic leading to positive stock performance"  
[X Link](https://x.com/Generic_Tina/status/1978661813551239638) [@Generic_Tina](/creator/x/Generic_Tina) 2025-10-16T03:18Z XX followers, XX engagements


"Top Glove Corp's revenue grew XX% YoY to RM 3.5B in FY25 driven by a XX% increase in sales volume amid competitive pricing. Positive outlook on stock as margin improved alongside volume growth"  
[X Link](https://x.com/Generic_Tina/status/1978983108612624775) [@Generic_Tina](/creator/x/Generic_Tina) 2025-10-17T00:35Z XX followers, XX engagements


"Hansoh and Leads Biolabs bag global outlicensing deals. Chugais partner Lilly announced positive P3 result for orforglipron. Celltrion launched Actemra biosimilar in US"  
[X Link](https://x.com/Generic_Tina/status/1979707871999983865) [@Generic_Tina](/creator/x/Generic_Tina) 2025-10-19T00:35Z XX followers, XX engagements


"Hansoh granted Roche exclusive license for CDH17-targeting ADC HS-20110. CDH17 targeted drug development scene is crowded. Hansohs strong execution with Roches global prowess will give it an edge"  
[X Link](https://x.com/Generic_Tina/status/1980070267860009308) [@Generic_Tina](/creator/x/Generic_Tina) 2025-10-20T00:35Z XX followers, XX engagements


"Bama Tea (BAMA HK) launched Hong Kong IPO. Bama specializes in tea leaf products in China. Pure volume play with branded offerings in a fragmented market. We would recommend to subscribe the issue"  
[X Link](https://x.com/Generic_Tina/status/1980432680786489760) [@Generic_Tina](/creator/x/Generic_Tina) 2025-10-21T00:35Z XX followers, XX engagements